Study to Evaluate the Safety and Efficacy of E/C/F/TAF (Genvoya®) Versus E/C/F/TDF (Stribild®) in HIV-1 Positive, Antiretroviral Treatment-Naive Adults
Completed · Phase 3 · Has a placebo group
Conditions studied: HIV, HIV Infections
In brief
The primary objective of this study is to evaluate the efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide (E/C/F/TAF) fixed-dose combination (FDC) versus elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate (E/C/F/TDF) FDC in HIV-1 positive, antiretroviral treatment-naive adults.
Key facts
- Study ID
- NCT01780506
- Run by
- Gilead Sciences
- People needed
- 872
- Starts
- 2012-12-26
- Expected to finish
- 2017-09-06
- Last updated by the study team
- 2018-11-19
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Spectrum Medical Group — Phoenix, Arizona, United States
- Kaiser Permanente Los Angeles — Los Angeles, California, United States
- University of California, Los Angeles — Los Angeles, California, United States
- Peter J. Ruane, MD, Inc. — Los Angeles, California, United States
- Anthony Mills MD Inc — Los Angeles, California, United States
- East Bay AIDS Center — Oakland, California, United States
- Kaiser Permanente - Sacramento — Sacramento, California, United States
- La Playa Medical Group and Clinical Research — San Diego, California, United States
- University of California, San Diego — San Diego, California, United States
- Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center — Torrance, California, United States
- Apex Research, LLC — Denver, Colorado, United States
- Yale University School of Medicine — New Haven, Connecticut, United States
- Dupont Circle Physicians Group, P.C. — Washington D.C., District of Columbia, United States
- Whitman Walker Clinic — Washington D.C., District of Columbia, United States
- Capital Medical Associates, P.C. — Washington D.C., District of Columbia, United States
- Gary Richmond, MD, PA, Inc. — Fort Lauderdale, Florida, United States
- Midway Immunology & Research Center, LLC — Ft. Pierce, Florida, United States
- The Kinder Medical Group — Miami, Florida, United States
- AIDS Healthcare Foundation — Miami Beach, Florida, United States
- Orlando Immunology Center — Orlando, Florida, United States
- IDOCF/ValuHealthMD, LLC — Orlando, Florida, United States
- Infectious Diseases Associates — Pensacola, Florida, United States
- The University of South Florida — Tampa, Florida, United States
- Infectious Disease Research Institute Inc. — Tampa, Florida, United States
- The University of Alabama at Birmingham — Birmingham, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.